Literature DB >> 9516924

Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.

M Behn1, S Qun, W Pankow, K Havemann, M Schuermann.   

Abstract

RFLP-mediated PCR has been successfully applied as a reliable tool in the detection of ras mutations in many cancers and provides a basis for "mutant-enriched PCR" protocols. We have, therefore, modified this technique to the sensitive detection of K-ras codon 12 and also p53 "hot spot" mutations, which, frequently in lung cancer, affect codons at the positions 157, 175, 245, 248, 249, and 273. With a high sensitivity of 1 mutant allele in 10(4) normal alleles, our enrichment assay allows the detection of oncogene alleles when only a few tumor cells are present within a normal cell population. Brush cytology material obtained from the tumor site of 20 patients with endoscopically apparent bronchial carcinoma was compared to macroscopically normal mucosa taken from the contralateral bronchus ("control" cytology). We found K-ras codon 12 mutations in 5 cases (25%) and p53 mutations in 13 cases (65%) in the tumor-derived cell material but, with the exception of two cases, not in cell material taken from the control cytology. Seventy-five % of the samples analyzed showed that at least one of the two oncogenes was affected. In several cases, two p53 lesions were detected concomitantly. The majority of the mutations could be reconfirmed by an alternative approach exploiting changes in the genomic RFLP pattern induced by these mutations and were also demonstrated in separate diagnostic biopsies taken. Thus, we conclude that the established enriched PCR protocol ensures a high sensitivity and preserved specificity for the diagnosis of oncogene lesions associated with lung cancer. Because conventional techniques normally yield a lower incidence of corresponding ras and p53 mutations, we think that both the high rate and the heterogeneity of p53 mutations found in some cases are, indeed, related to the increased sensitivity of this new enriched PCR technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516924

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  6 in total

Review 1.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

2.  Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.

Authors:  Jin Li; Coren A Milbury; Cheng Li; G Mike Makrigiorgos
Journal:  Hum Mutat       Date:  2009-11       Impact factor: 4.878

3.  Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.

Authors:  T Urban; S Ricci; C Danel; M Antoine; M Kambouchner; V Godard; R Lacave; J F Bernaudin
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.

Authors:  Christine Mölzer; Barbara Pfleger; Elisabeth Putz; Antonia Roßmann; Ursula Schwarz; Marlies Wallner; Andrew C Bulmer; Karl-Heinz Wagner
Journal:  Exp Cell Res       Date:  2012-12-13       Impact factor: 3.905

5.  s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis.

Authors:  Jin Li; Ross Berbeco; Robert J Distel; Pasi A Jänne; Lilin Wang; G Mike Makrigiorgos
Journal:  Nucleic Acids Res       Date:  2007-06-01       Impact factor: 16.971

6.  A novel RFLP-ARMS TaqMan PCR-based method for detecting the BRAF V600E mutation in melanoma.

Authors:  Yunqing Zhang; Shoufang Qu; Jinyin Zhao; Ting Yu; Liping Guo; Songchao Yin; Xiaoxu Hu; Weijun Chen; Wei Lai; Jie Huang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.